Amgen’s Kyprolis Meets Phase 3 Primary Goal

Amgen’s Kyprolis Meets Phase 3 Primary Goal

Amgen’s Phase 3 trial of Kyprolis was successful; patients’ progression-free survival increased

By Staff Writer on Aug 4, 2014 at 7:31 pm EST

Amgen’s Kyprolis Meets Phase 3 Primary Goal
comments powered by Disqus